- Bill Janzen, University of North Carolina at Chapel Hill, USA, Chair
- Maria Webb, Ligand Pharmaceuticals, USA, SBS Board Liaison
- Frank Fan, Promega Corporation, USA
- David Dunn, Wyeth Research, USA
- Marcie Glicksman, Brigham & Women’s Hospital, USA
- Keith Houck, Environmental Protection Agency, USA
- Kelvin Lam, Harvard University, USA
- Chris Lipinski, Melior Discovery, USA
- Julio Martin, GlaxoSmithKline, Spain
- Richard Pither, UCB Celltech, UK
- Steve Rees, GlaxoSmithKline, UK
- Achim von Leoprechting, PerkinElmer Bio-discovery, Germany
- Jennings Worley, Vertex Pharmaceuticals, USA
- Christine Giordano, CAE, SBS
- Marietta Manoni, CMP, SBS
|
|
|
